
NCBI . NLM . NIH . GOV {
}
Title[redir]:
AXL mediates resistance to cetuximab therapy - PMC
Description:
The EGFR antibody cetuximab is used to treat numerous cancers, but intrinsic and acquired resistance to this agent is a common clinical problem. In this study we show that overexpression of the oncogenic receptor kinase AXL is sufficient to mediate ...
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is ncbi.nlm.nih.gov built with?
Custom-built
No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of ncbi.nlm.nih.gov audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 6,732,313 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Ncbi.nlm.nih.gov Make Money? {💸}
We're unsure if the website is profiting.
Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Ncbi.nlm.nih.gov could be secretly minting cash, but we can't detect the process.
Keywords {🔍}
axl, cetuximab, doi, egfr, cells, ctxr, resistance, cell, cancer, clones, figure, pubmed, google, scholar, expression, growth, activation, proliferation, signaling, pmc, tumors, acquired, resistant, mapk, article, data, treated, analysis, free, receptor, hnscc, tyrosine, sirna, increased, tumor, control, igg, antibody, role, treatment, pdxs, usa, mab, mrna, antiaxl, prior, kinase, overexpressed, factor, line,
Topics {✒️}
hrp-conjugated goat-anti-rabbit igg robust anti-proliferative responses robust anti-proliferative effects elicited anti-proliferative responses patient-derived tumor xenografts donkey-anti-goat igg bamh1/ecor1 restriction sites triple-negative breast cancers patient-derived xenografts established anti-axl monoclonal antibody pmc beta search ras/raf/mek/erk mapk/c-jun signaling pathway goat-anti-mouse igg small-cell lung cancer line taxane/carboplatin chemotherapy transcription factor c-jun early-stage colon cancer shown anti-tumorigenic effects hyperactivated mapk/c-jun signaling phospho axl-y779 antibody ctxr clones post-treatment ctxs cell line de novo models treat cetuximab-resistant cancers tumor xenograft assays squamous-cell carcinoma hp-axl stable cells united states government paxl-y779 expression levels gene expression profile anti-axl tki r428 small interfering rna receptor tyrosine kinases license information pmcid monoclonal antibody mab173 supplementary materials included single cell clones cetuximab-sensitive parental cells nih national center egfr-dependent ctxr cells researchers demonstrated axl ctxs parental cells growth inhibitory effects igg grew rapidly anti-axl antibody early passaged pdxs axl receptor played egfr kinase inhibitors positive feedback loop
Social Networks {👍}(6)
External Links {🔗}(108)
- Revenue of https://doi.org/10.1158/0008-5472.CAN-14-0294
- Earnings of https://doi.org/10.1016/S0065-230X(08)00002-X
- What's the monthly income of https://scholar.google.com/scholar_lookup?journal=Advances%20in%20cancer%20research&title=TAM%20receptor%20tyrosine%20kinases:%20biologic%20functions,%20signaling,%20and%20potential%20therapeutic%20targeting%20in%20human%20cancer.&author=RM%20Linger&author=AK%20Keating&author=HS%20Earp&author=DK%20Graham&volume=100&publication_year=2008&pages=35-83&pmid=18620092&doi=10.1016/S0065-230X(08)00002-X&?
- Find out how much https://doi.org/10.1158/1535-7163.MCT-11-0116 earns monthly
- How much profit does https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&title=Targeting%20AXL%20and%20Mer%20kinases%20in%20cancer.&author=A%20Verma&author=SL%20Warner&author=H%20Vankayalapati&author=DJ%20Bearss&author=S%20Sharma&volume=10&publication_year=2011&pages=1763-73&pmid=21933973&doi=10.1158/1535-7163.MCT-11-0116& generate?
- How much revenue does https://doi.org/10.1038/onc.2009.212 produce monthly?
- Earnings of https://scholar.google.com/scholar_lookup?journal=Oncogene&title=AXL%20as%20a%20potential%20therapeutic%20target%20in%20cancer:%20role%20of%20AXL%20in%20tumor%20growth,%20metastasis%20and%20angiogenesis.&author=Y%20Li&author=X%20Ye&author=C%20Tan&author=JA%20Hongo&author=J%20Zha&volume=28&publication_year=2009&pages=3442-55&pmid=19633687&doi=10.1038/onc.2009.212&
- What are the total earnings of https://doi.org/10.1517/14728222.2010.515980?
- How much does https://scholar.google.com/scholar_lookup?journal=Expert%20opinion%20on%20therapeutic%20targets&title=Taking%20aim%20at%20Mer%20and%20AXL%20receptor%20tyrosine%20kinases%20as%20novel%20therapeutic%20targets%20in%20solid%20tumors.&author=RM%20Linger&author=AK%20Keating&author=HS%20Earp&author=DK%20Graham&volume=14&publication_year=2010&pages=1073-90&pmid=20809868&doi=10.1517/14728222.2010.515980& pull in monthly?
- See how much https://doi.org/10.1002/ijc.28246 makes per month
- Revenue of https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&title=The%20receptor%20tyrosine%20kinase%20AXL%20in%20cancer:%20Biological%20functions%20and%20therapeutic%20implications.&author=JD%20Paccez&author=M%20Vogelsang&author=MI%20Parker&author=LF%20Zerbini&volume=134&publication_year=2014&pages=1024-33&pmid=23649974&doi=10.1002/ijc.28246&
- How much profit does https://doi.org/10.1158/0008-5472.CAN-07-2661 make?
- How much does https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=AXL%20is%20a%20potential%20target%20for%20therapeutic%20intervention%20in%20breast%20cancer%20progression.&author=YX%20Zhang&author=PG%20Knyazev&author=YV%20Cheburkin&author=K%20Sharma&author=YP%20Knyazev&volume=68&publication_year=2008&pages=1905-15&pmid=18339872&doi=10.1158/0008-5472.CAN-07-2661& generate monthly?
- How much does https://doi.org/10.1158/0008-5472.CAN-10-1267 pull in?
- How much revenue does https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=AXL%20is%20an%20essential%20factor%20and%20therapeutic%20target%20for%20metastatic%20ovarian%20cancer.&author=EB%20Rankin&author=KC%20Fuh&author=TE%20Taylor&author=AJ%20Krieg&author=M%20Musser&volume=70&publication_year=2010&pages=7570-9&pmid=20858715&doi=10.1158/0008-5472.CAN-10-1267& produce monthly?
- How much does https://doi.org/10.1038/onc.2012.89 generate monthly?
- How much money does https://scholar.google.com/scholar_lookup?journal=Oncogene&title=The%20receptor%20tyrosine%20kinase%20AXL%20is%20an%20essential%20regulator%20of%20prostate%20cancer%20proliferation%20and%20tumor%20growth%20and%20represents%20a%20new%20therapeutic%20target.&author=JD%20Paccez&author=GJ%20Vasques&author=RG%20Correa&author=JF%20Vasconcellos&author=K%20Duncan&volume=32&publication_year=2013&pages=689-98&pmid=22410775&doi=10.1038/onc.2012.89& make?
- Get to know https://doi.org/10.1182/blood-2009-12-257154's earnings
- How much does https://scholar.google.com/scholar_lookup?journal=Blood&title=Induction,%20regulation,%20and%20biologic%20function%20of%20AXL%20receptor%20tyrosine%20kinase%20in%20Kaposi%20sarcoma.&author=R%20Liu&author=M%20Gong&author=X%20Li&author=Y%20Zhou&author=W%20Gao&volume=116&publication_year=2010&pages=297-305&pmid=20442363&doi=10.1182/blood-2009-12-257154& bring in each month?
- How much money does https://doi.org/10.1038/onc.2012.355 make?
- Learn how profitable https://scholar.google.com/scholar_lookup?journal=Oncogene&title=Mer%20or%20AXL%20receptor%20tyrosine%20kinase%20inhibition%20promotes%20apoptosis,%20blocks%20growth%20and%20enhances%20chemosensitivity%20of%20human%20non-small%20cell%20lung%20cancer.&author=RM%20Linger&author=RA%20Cohen&author=CT%20Cummings&author=S%20Sather&author=J%20Migdall-Wilson&volume=32&publication_year=2013&pages=3420-31&pmid=22890323&doi=10.1038/onc.2012.355& is on a monthly basis
- How much does https://doi.org/10.1016/j.bbrc.2013.05.019 earn?
- How much does https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&title=Gas6/AXL%20mediates%20tumor%20cell%20apoptosis,%20migration%20and%20invasion%20and%20predicts%20the%20clinical%20outcome%20of%20osteosarcoma%20patients.&author=J%20Han&author=R%20Tian&author=B%20Yong&author=C%20Luo&author=P%20Tan&volume=435&publication_year=2013&pages=493-500&pmid=23684620&doi=10.1016/j.bbrc.2013.05.019& earn?
- Find out how much https://doi.org/10.1158/1078-0432.CCR-12-1558 earns monthly
- How much does https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=An%20epithelial-mesenchymal%20transition%20gene%20signature%20predicts%20resistance%20to%20EGFR%20and%20PI3K%20inhibitors%20and%20identifies%20AXL%20as%20a%20therapeutic%20target%20for%20overcoming%20EGFR%20inhibitor%20resistance.&author=LA%20Byers&author=L%20Diao&author=J%20Wang&author=P%20Saintigny&author=L%20Girard&volume=19&publication_year=2013&pages=279-90&pmid=23091115&doi=10.1158/1078-0432.CCR-12-1558& net monthly?
- How much profit does https://doi.org/10.1158/1535-7163.MCT-13-0170 generate?
- What's the revenue for https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&title=AXL%20mediates%20acquired%20resistance%20of%20head%20and%20neck%20cancer%20cells%20to%20the%20epidermal%20growth%20factor%20receptor%20inhibitor%20erlotinib.&author=KM%20Giles&author=FC%20Kalinowski&author=PA%20Candy&author=MR%20Epis&author=PM%20Zhang&volume=12&publication_year=2013&pages=2541-58&pmid=24026012&doi=10.1158/1535-7163.MCT-13-0170&?
- What's the monthly money flow for https://doi.org/10.1126/scisignal.2004155?
- Revenue of https://scholar.google.com/scholar_lookup?journal=Sci%20Signal&title=The%20receptor%20AXL%20diversifies%20EGFR%20signaling%20and%20limits%20the%20response%20to%20EGFR-targeted%20inhibitors%20in%20triple-negative%20breast%20cancer%20cells.&author=AS%20Meyer&author=MA%20Miller&author=FB%20Gertler&author=DA%20Lauffenburger&volume=6&publication_year=2013&pages=ra66&pmid=23921085&doi=10.1126/scisignal.2004155&
- How much revenue does https://doi.org/10.1038/onc.2010.268 produce monthly?
- Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Oncogene&title=An%20anti-AXL%20monoclonal%20antibody%20attenuates%20xenograft%20tumor%20growth%20and%20enhances%20the%20effect%20of%20multiple%20anticancer%20therapies.&author=X%20Ye&author=Y%20Li&author=S%20Stawicki&author=S%20Couto&author=J%20Eastham-Anderson&volume=29&publication_year=2010&pages=5254-64&pmid=20603615&doi=10.1038/onc.2010.268&
- How much does https://doi.org/10.1038/ng.2330 generate monthly?
- How much income does https://scholar.google.com/scholar_lookup?journal=Nature%20genetics&title=Activation%20of%20the%20AXL%20kinase%20causes%20resistance%20to%20EGFR-targeted%20therapy%20in%20lung%20cancer.&author=Z%20Zhang&author=JC%20Lee&author=L%20Lin&author=V%20Olivas&author=V%20Au&volume=44&publication_year=2012&pages=852-60&pmid=22751098&doi=10.1038/ng.2330& have?
- How much revenue does https://doi.org/10.1158/0008-5472.CAN-13-1103 generate?
- Explore the financials of https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=MET%20and%20AXL%20Inhibitor%20NPS-1034%20Exerts%20Efficacy%20against%20Lung%20Cancer%20Cells%20Resistant%20to%20EGFR%20Kinase%20Inhibitors%20Because%20of%20MET%20or%20AXL%20Activation.&author=JK%20Rho&author=YJ%20Choi&author=SY%20Kim&author=TW%20Kim&author=EK%20Choi&volume=74&publication_year=2014&pages=253-62&pmid=24165158&doi=10.1158/0008-5472.CAN-13-1103&
- How much money does https://doi.org/10.1158/1078-0432.CCR-13-1354 generate?
- Learn about the earnings of https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=AXL%20Is%20a%20Key%20Regulator%20of%20Inherent%20and%20Chemotherapy-Induced%20Invasion%20and%20Predicts%20a%20Poor%20Clinical%20Outcome%20in%20Early-Stage%20Colon%20Cancer.&author=PD%20Dunne&author=DG%20McArt&author=JK%20Blayney&author=M%20Kalimutho&author=S%20Greer&volume=20&publication_year=2014&pages=164-75&pmid=24170546&doi=10.1158/1078-0432.CCR-13-1354&
- Learn about the earnings of https://doi.org/10.1016/s0959-8049(01)00233-7
- https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cancer&title=The%20EGFR%20as%20a%20target%20for%20anticancer%20therapy--focus%20on%20cetuximab.&author=J%20Baselga&volume=37&issue=Suppl%204&publication_year=2001&pages=S16-22&pmid=11597400&doi=10.1016/s0959-8049(01)00233-7&'s revenue stream
- How much does https://doi.org/10.1056/NEJMoa053422 make?
- https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Radiotherapy%20plus%20cetuximab%20for%20squamous-cell%20carcinoma%20of%20the%20head%20and%20neck.&author=JA%20Bonner&author=PM%20Harari&author=J%20Giralt&author=N%20Azarnia&author=DM%20Shin&volume=354&publication_year=2006&pages=567-78&pmid=16467544&doi=10.1056/NEJMoa053422&'s financial summary
- https://doi.org/10.1158/1078-0432.CCR-040015's total income per month
- How much cash flow does https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&title=Cetuximab%20in%20advanced%20non-small%20cell%20lung%20cancer.&author=R%20Govindan&volume=10&publication_year=2004&pages=4241S-4S&pmid=15217966&doi=10.1158/1078-0432.CCR-040015& have monthly?
- How much does https://doi.org/10.1016/S0140-6736(09)60569-9 pull in monthly?
- What's the income generated by https://scholar.google.com/scholar_lookup?journal=Lancet&title=Cetuximab%20plus%20chemotherapy%20in%20patients%20with%20advanced%20non-small-cell%20lung%20cancer%20(FLEX):%20an%20open-label%20randomised%20phase%20III%20trial.&author=R%20Pirker&author=JR%20Pereira&author=A%20Szczesna&author=J%20von%20Pawel&author=M%20Krzakowski&volume=373&publication_year=2009&pages=1525-31&pmid=19410716&doi=10.1016/S0140-6736(09)60569-9& each month?
- What's the revenue for https://doi.org/10.1200/JCO.2005.03.1997?
- Income figures for https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&title=Multicenter%20phase%20I/II%20study%20of%20cetuximab%20with%20paclitaxel%20and%20carboplatin%20in%20untreated%20patients%20with%20stage%20IV%20non-small-cell%20lung%20cancer.&author=CD%20Thienelt&author=PA%20Bunn&author=N%20Hanna&author=A%20Rosenberg&author=MN%20Needle&volume=23&publication_year=2005&pages=8786-93&pmid=16246975&doi=10.1200/JCO.2005.03.1997&
- How much income is https://doi.org/10.1056/NEJMoa0805019 earning monthly?
- Revenue of https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Cetuximab%20and%20chemotherapy%20as%20initial%20treatment%20for%20metastatic%20colorectal%20cancer.&author=E%20Van%20Cutsem&author=CH%20Kohne&author=E%20Hitre&author=J%20Zaluski&author=CR%20Chang%20Chien&volume=360&publication_year=2009&pages=1408-17&pmid=19339720&doi=10.1056/NEJMoa0805019&
- What's the income generated by https://doi.org/10.1056/NEJMoa0802656 each month?
- How much does https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Platinum-based%20chemotherapy%20plus%20cetuximab%20in%20head%20and%20neck%20cancer.&author=JB%20Vermorken&author=R%20Mesia&author=F%20Rivera&author=E%20Remenar&author=A%20Kawecki&volume=359&publication_year=2008&pages=1116-27&pmid=18784101&doi=10.1056/NEJMoa0802656& gross monthly?
- Check the income stats for https://doi.org/10.1200/JCO.2009.21.9618
- What is the earnings of https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Cetuximab%20and%20first-line%20taxane/carboplatin%20chemotherapy%20in%20advanced%20non-small-cell%20lung%20cancer:%20results%20of%20the%20randomized%20multicenter%20phase%20III%20trial%20BMS099.&author=TJ%20Lynch&author=T%20Patel&author=L%20Dreisbach&author=M%20McCleod&author=WJ%20Heim&volume=28&publication_year=2010&pages=911-7&pmid=20100966&doi=10.1200/JCO.2009.21.9618&?
- Revenue of https://doi.org/10.1200/JCO.2009.24.6116
- What's the income generated by https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Molecular%20mechanisms%20of%20resistance%20to%20cetuximab%20and%20panitumumab%20in%20colorectal%20cancer.&author=A%20Bardelli&author=S%20Siena&volume=28&publication_year=2010&pages=1254-61&pmid=20100961&doi=10.1200/JCO.2009.24.6116& each month?
- Earnings of https://doi.org/10.4161/cbt.11.9.15050
- What's the income generated by https://scholar.google.com/scholar_lookup?journal=Cancer%20Biol%20Ther&title=Molecular%20mechanisms%20of%20resistance%20to%20the%20EGFR%20monoclonal%20antibody%20cetuximab.&author=TM%20Brand&author=M%20Iida&author=DL%20Wheeler&volume=11&publication_year=2011&pages=777-92&pmid=21293176&doi=10.4161/cbt.11.9.15050& each month?
- What's https://doi.org/10.1038/nature11219's gross income?
- How much does https://scholar.google.com/scholar_lookup?journal=Nature&title=The%20molecular%20evolution%20of%20acquired%20resistance%20to%20targeted%20EGFR%20blockade%20in%20colorectal%20cancers.&author=LA%20Diaz&author=RT%20Williams&author=J%20Wu&author=I%20Kinde&author=JR%20Hecht&volume=486&publication_year=2012&pages=537-40&pmid=22722843&doi=10.1038/nature11219& pull in monthly?
- What is the monthly revenue of https://doi.org/10.1038/onc.2008.19?
- How profitable is https://scholar.google.com/scholar_lookup?journal=Oncogene&title=Mechanisms%20of%20acquired%20resistance%20to%20cetuximab:%20role%20of%20HER%20(ErbB)%20family%20members.&author=DL%20Wheeler&author=S%20Huang&author=TJ%20Kruser&author=MM%20Nechrebecki&author=EA%20Armstrong&volume=27&publication_year=2008&pages=3944-56&pmid=18297114&doi=10.1038/onc.2008.19&?
- How much does https://doi.org/10.1593/neo.131584 bring in each month?
- Monthly income for https://scholar.google.com/scholar_lookup?journal=Neoplasia&title=Sym004,%20a%20Novel%20EGFR%20Antibody%20Mixture,%20Can%20Overcome%20Acquired%20Resistance%20to%20Cetuximab.&author=M%20Iida&author=TM%20Brand&author=MM%20Starr&author=C%20Li&author=EJ%20Huppert&volume=15&publication_year=2013&pages=1196-206&pmid=24204198&doi=10.1593/neo.131584&
- Monthly income for https://doi.org/10.4161/cbt.12.5.16394
- Profit of https://scholar.google.com/scholar_lookup?journal=Cancer%20Biol%20Ther&title=Erlotinib%20is%20a%20viable%20treatment%20for%20tumors%20with%20acquired%20resistance%20to%20cetuximab.&author=TM%20Brand&author=EF%20Dunn&author=M%20Iida&author=RA%20Myers&author=KT%20Kostopoulos&volume=12&publication_year=2011&pages=436-46&pmid=21725209&doi=10.4161/cbt.12.5.16394&
- https://doi.org/10.1038/onc.2012.90 income
- Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Oncogene&title=Yes%20and%20Lyn%20play%20a%20role%20in%20nuclear%20translocation%20of%20the%20epidermal%20growth%20factor%20receptor.&author=M%20Iida&author=TM%20Brand&author=DA%20Campbell&author=C%20Li&author=DL%20Wheeler&volume=32&publication_year=2013&pages=759-67&pmid=22430206&doi=10.1038/onc.2012.90&
- What are the earnings of https://doi.org/10.1371/journal.pone.0071518?
- What's the financial intake of https://scholar.google.com/scholar_lookup?journal=PLoS%20One&title=Mapping%20C-terminal%20transactivation%20domains%20of%20the%20nuclear%20HER%20family%20receptor%20tyrosine%20kinase%20HER3.&author=TM%20Brand&author=M%20Iida&author=N%20Luthar&author=MJ%20Wleklinski&author=MM%20Starr&volume=8&publication_year=2013&pages=e71518&pmid=23951180&doi=10.1371/journal.pone.0071518&?
- How much does https://scholar.google.com/scholar_lookup?journal=Discov%20Med&title=Human%20epidermal%20growth%20factor%20receptor%203%20(HER3)%20blockade%20with%20U3-1287/AMG888%20enhances%20the%20efficacy%20of%20radiation%20therapy%20in%20lung%20and%20head%20and%20neck%20carcinoma.&author=C%20Li&author=TM%20Brand&author=M%20Iida&author=S%20Huang&author=EA%20Armstrong&volume=16&publication_year=2013&pages=79-92&pmid=23998444& gross monthly?
- How much does https://doi.org/10.1038/onc.2009.234 net monthly?
- Monthly income for https://scholar.google.com/scholar_lookup?journal=Oncogene&title=Nuclear%20EGFR%20contributes%20to%20acquired%20resistance%20to%20cetuximab.&author=C%20Li&author=M%20Iida&author=EF%20Dunn&author=AJ%20Ghia&author=DL%20Wheeler&volume=28&publication_year=2009&pages=3801-13&pmid=19684613&doi=10.1038/onc.2009.234&
- How much money does https://doi.org/10.1038/nrc3309 make?
- How much money does https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&title=The%20ERBB%20network:%20at%20last,%20cancer%20therapy%20meets%20systems%20biology.&author=Y%20Yarden&author=G%20Pines&volume=12&publication_year=2012&pages=553-63&pmid=22785351&doi=10.1038/nrc3309& make?
- How much cash flow does https://doi.org/10.1042/BC20100094 have monthly?
- Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Biology%20of%20the%20cell%20/%20under%20the%20auspices%20of%20the%20European%20Cell%20Biology%20Organization&title=PMA%20up-regulates%20the%20transcription%20of%20AXL%20by%20AP-1%20transcription%20factor%20binding%20to%20TRE%20sequences%20via%20the%20MAPK%20cascade%20in%20leukaemia%20cells.&author=G%20Mudduluru&author=JH%20Leupold&author=P%20Stroebel&author=H%20Allgayer&volume=103&publication_year=2010&pages=21-33&pmid=20977427&doi=10.1042/BC20100094&
- How much money does https://doi.org/10.1128/mcb.11.3.1480 make?
- Revenue of https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biology&title=An%20%E2%80%9Cattenuator%20domain%E2%80%9D%20is%20sandwiched%20by%20two%20distinct%20transactivation%20domains%20in%20the%20transcription%20factor%20C/EBP.&author=DQ%20Pei&author=CH%20Shih&volume=11&publication_year=1991&pages=1480-7&pmid=1996105&doi=10.1128/mcb.11.3.1480&
- How much money does https://doi.org/10.1158/0008-5472.CAN-09-2997 generate?
- Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=R428,%20a%20selective%20small%20molecule%20inhibitor%20of%20AXL%20kinase,%20blocks%20tumor%20spread%20and%20prolongs%20survival%20in%20models%20of%20metastatic%20breast%20cancer.&author=SJ%20Holland&author=A%20Pan&author=C%20Franci&author=Y%20Hu&author=B%20Chang&volume=70&publication_year=2010&pages=1544-54&pmid=20145120&doi=10.1158/0008-5472.CAN-09-2997&
- What's the revenue for https://doi.org/10.1038/nm.2609?
- What's the total monthly financial gain of https://scholar.google.com/scholar_lookup?journal=Nat%20Med&title=Identification%20of%20a%20mutation%20in%20the%20extracellular%20domain%20of%20the%20Epidermal%20Growth%20Factor%20Receptor%20conferring%20cetuximab%20resistance%20in%20colorectal%20cancer.&author=C%20Montagut&author=A%20Dalmases&author=B%20Bellosillo&author=M%20Crespo&author=S%20Pairet&volume=18&publication_year=2012&pages=221-3&pmid=22270724&doi=10.1038/nm.2609&?
- How much income is https://doi.org/10.1371/journal.pone.0012702 earning monthly?
- Income figures for https://scholar.google.com/scholar_lookup?journal=Plos%20One&title=Regulation%20of%20Heparin-Binding%20EGF-Like%20Growth%20Factor%20by%20miR-212%20and%20Acquired%20Cetuximab-Resistance%20in%20Head%20and%20Neck%20Squamous%20Cell%20Carcinoma.&author=H%20Hatakeyama&author=HX%20Cheng&author=P%20Wirth&author=A%20Counsell&author=SR%20Marcrom&volume=5&publication_year=2010&pmid=20856931&doi=10.1371/journal.pone.0012702&
- What's https://doi.org/10.1158/1078-0432.CCR-07-4905's gross income?
- How much does https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Vascular%20endothelial%20growth%20factor%20receptor-1%20contributes%20to%20resistance%20to%20anti-epidermal%20growth%20factor%20receptor%20drugs%20in%20human%20cancer%20cells.&author=R%20Bianco&author=R%20Rosa&author=V%20Damiano&author=G%20Daniele&author=T%20Gelardi&volume=14&publication_year=2008&pages=5069-80&pmid=18694994&doi=10.1158/1078-0432.CCR-07-4905& rake in every month?
- Get to know https://doi.org/10.1038/nrclinonc.2009.111's earnings
- How profitable is https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&title=Implications%20for%20KRAS%20status%20and%20EGFR-targeted%20therapies%20in%20metastatic%20CRC.&author=N%20Normanno&author=S%20Tejpar&author=F%20Morgillo&author=A%20De%20Luca&author=E%20Van%20Cutsem&volume=6&publication_year=2009&pages=519-27&pmid=19636327&doi=10.1038/nrclinonc.2009.111&?
- Check the income stats for https://doi.org/10.4161/cbt.8.8.7903
- How much revenue does https://scholar.google.com/scholar_lookup?journal=Cancer%20Biol%20Ther&title=Epidermal%20growth%20factor%20receptor%20cooperates%20with%20Src%20family%20kinases%20in%20acquired%20resistance%20to%20cetuximab.&author=DL%20Wheeler&author=M%20Iida&author=TJ%20Kruser&author=MM%20Nechrebecki&author=EF%20Dunn&volume=8&publication_year=2009&pages=696-703&pmid=19276677&doi=10.4161/cbt.8.8.7903& generate?
- What is the earnings of https://doi.org/10.1158/0008-5472.CAN-13-1069?
- What's the income generated by https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=Patient-derived%20tumor%20xenografts:%20transforming%20clinical%20samples%20into%20mouse%20models.&author=D%20Siolas&author=GJ%20Hannon&volume=73&publication_year=2013&pages=5315-9&pmid=23733750&doi=10.1158/0008-5472.CAN-13-1069& each month?
- Financial intake of https://doi.org/10.1158/1078-0432.CCR-12-2746
- How much money does https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Development%20and%20characterization%20of%20HPV-positive%20and%20HPV-negative%20head%20and%20neck%20squamous%20cell%20carcinoma%20tumorgrafts.&author=RJ%20Kimple&author=PM%20Harari&author=AD%20Torres&author=RZ%20Yang&author=BJ%20Soriano&volume=19&publication_year=2013&pages=855-64&pmid=23251001&doi=10.1158/1078-0432.CCR-12-2746& generate?
- Get to know https://doi.org/10.1158/1535-7163.MCT-13-1033's earnings
- How much does https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&title=ERBB3/HER2%20Signaling%20Promotes%20Resistance%20to%20EGFR%20Blockade%20in%20Head%20and%20Neck%20and%20Colorectal%20Cancer%20Models.&author=L%20Zhang&author=C%20Castanaro&author=B%20Luan&author=K%20Yang&author=L%20Fan&volume=13&publication_year=2014&pages=1345-55&pmid=24634416&doi=10.1158/1535-7163.MCT-13-1033& bring in each month?
- What's the income of https://github.com/ncbi?
- https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323's total income per month
- What's the revenue for https://www.nlm.nih.gov/web_policies.html?
- Revenue of https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office
- How much does https://www.hhs.gov/vulnerability-disclosure-policy/index.html generate monthly?
- What's the financial outcome of https://support.nlm.nih.gov/?pagename=cloudpmc-viewer%3Apmc%3Aarticle%3Amanuscript?
- https://www.nlm.nih.gov/accessibility.html's total income per month
- What's https://www.nlm.nih.gov/careers/careers.html's gross income?
- What's https://www.nlm.nih.gov/'s gross income?
- What are the earnings of https://www.nih.gov/?
- How much does https://www.hhs.gov/ pull in?
- How much money does https://www.usa.gov/ generate?
Analytics and Tracking {📊}
- Google Analytics
- Google Analytics 4
- Google Tag Manager
Libraries {📚}
- jQuery
- jQuery module (jquery-3.6.0)
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- nihcesxway.hub.nih.gov
- nihcesxway2.hub.nih.gov
- nihcesxway3.hub.nih.gov
- nihcesxway4.hub.nih.gov
- nihcesxway5.hub.nih.gov
Name Servers:
- dns1-ncbi.ncbi.nlm.nih.gov
- dns2-ncbi.ncbi.nlm.nih.gov
- lhcns1.nlm.nih.gov
- lhcns2.nlm.nih.gov
CDN Services {📦}
- Ncbi